This trial looks at how often three different viruses - RSV, influenza, and SARS-CoV-2 - cause respiratory infections in people at high risk for severe illness. It also looks at whether RSV is linked to hospitalization for respiratory illness.
4 Primary · 18 Secondary · Reporting Duration: Up to 3 months
2960 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase < 1
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: